Nano-enabled fermented brown rice peptides present a novel strategy for stress resilience and neuroprotection

Functional foods are rapidly evolving, shifting focus from traditional polyphenols to peptide-driven bioactivity derived from microbial fermentation. This transition addresses a growing demand for natural, effective interventions against stress-induced neurological decline and for promoting overall neuroprotection. Current approaches often lack the targeted efficacy or bioavailability needed for optimal brain health. Bioactive peptides (BAPs), short amino acid sequences, offer diverse biological properties, making them attractive candidates for novel functional food applications. Fermented brown rice, particularly with strains like Limosilactobacillus reuteri, has emerged as a promising source of these multifunctional BAPs, exhibiting antioxidant and anti-inflammatory potential.

This work explores a novel conceptual framework for leveraging fermented brown rice-derived bioactive peptides through nano-enabled delivery systems. The authors investigate the theoretical underpinnings and potential mechanisms by which these peptides could enhance stress resilience and provide neuroprotection. While specific experimental protocols detailing dose, route, or duration are not provided in the abstract, the paper focuses on the innovative integration of fermentation technology with advanced nanotechnology to optimize peptide bioavailability and targeted action for functional food development.

The core finding is the identification and conceptualization of nano-enabled delivery as a promising strategy to enhance the efficacy of fermented brown rice-derived bioactive peptides. This approach is posited to unlock significant potential for improving stress resilience and offering robust neuroprotection, thereby paving the way for innovative functional food applications. The paper highlights the synergistic benefits of microbial fermentation for peptide generation and nanotechnology for optimized delivery, suggesting a pathway to overcome bioavailability challenges inherent in traditional peptide administration and maximize therapeutic impact.